By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ)

SHZ Currency in CNY
¥3.55
¥0.00
0.00%
Last Update: 7 Jul 2025, 07:04
¥6.57B
Market Cap
31.47
P/E Ratio (TTM)
1.69%
Forward Dividend Yield
¥2.86 - ¥4.85
52 Week Range

002390.SZ Stock Price Chart

Explore Guizhou Xinbang Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002390.SZ price movements and trends.

There is nothing to show.

002390.SZ Company Profile

Discover essential business fundamentals and corporate details for Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

16 Apr 2010

Employees

5.06K

CEO

Lingzhong Kong

Description

Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of Chinese herbal medicines and biological drugs in China and internationally. It offers cardiovascular and cerebrovascular, digestive system, endocrine, tumor and immune regulation, blood system, rheumatism and rheumatoid, urinary system, antipyretic analgesic, cold medication, gynecological treatment, and anti-infective drugs. The company was founded in 1995 and is headquartered in Guiyang, China.

002390.SZ Financial Timeline

Browse a chronological timeline of Guizhou Xinbang Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 21 May 2025

A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 21 May 2025.

Earnings released on 29 Apr 2025

EPS came in at ¥0.02, while revenue for the quarter reached ¥1.44B.

Earnings released on 14 Apr 2025

EPS came in at -¥0.04, while revenue for the quarter reached ¥1.47B.

Earnings released on 30 Oct 2024

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.51B.

Dividend declared on 29 Oct 2024

A dividend of ¥0.03 per share was announced, adjusted to ¥0.03. The dividend was paid on 29 Oct 2024.

Earnings released on 30 Aug 2024

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.46B.

Dividend declared on 17 May 2024

A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 17 May 2024.

Earnings released on 15 Apr 2024

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.58B.

Earnings released on 22 Feb 2024

EPS came in at ¥0.02, while revenue for the quarter reached ¥1.63B.

Earnings released on 29 Oct 2023

EPS came in at ¥0.05, while revenue for the quarter reached ¥1.57B.

Earnings released on 28 Aug 2023

EPS came in at ¥0.05, while revenue for the quarter reached ¥1.65B.

Dividend declared on 30 May 2023

A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 30 May 2023.

Earnings released on 28 Apr 2023

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.61B.

Earnings released on 17 Apr 2023

EPS came in at -¥0.01, while revenue for the quarter reached ¥1.66B.

Earnings released on 28 Oct 2022

EPS came in at ¥0.06, while revenue for the quarter reached ¥1.54B.

Earnings released on 24 Aug 2022

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.57B.

Dividend declared on 24 May 2022

A dividend of ¥0.06 per share was announced, adjusted to ¥0.06. The dividend was paid on 24 May 2022.

Earnings released on 30 Apr 2022

EPS came in at ¥0.04, while revenue for the quarter reached ¥1.58B.

Earnings released on 14 Mar 2022

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.75B.

Earnings released on 28 Oct 2021

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.62B.

Earnings released on 26 Aug 2021

EPS came in at ¥0.05, while revenue for the quarter reached ¥1.64B.

Earnings released on 29 Apr 2021

EPS came in at ¥0.05, while revenue for the quarter reached ¥1.46B.

Earnings released on 30 Mar 2021

EPS came in at ¥0.03, while revenue for the quarter reached ¥1.57B.

Earnings released on 27 Oct 2020

EPS came in at ¥0.06, while revenue for the quarter reached ¥1.58B.

Earnings released on 27 Aug 2020

EPS came in at ¥0.04, while revenue for the quarter reached ¥1.46B.

002390.SZ Stock Performance

Access detailed 002390.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
002390.SZ
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
002390.SZ
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More